UniProt ID | LRC42_HUMAN | |
---|---|---|
UniProt AC | Q9Y546 | |
Protein Name | Leucine-rich repeat-containing protein 42 | |
Gene Name | LRRC42 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 428 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MSYYLSSENHLDPGPIYMRENGQLHMVNLALDGVRSSLQKPRPFRLFPKGFSVELCMNREDDTARKEKTDHFIFTYTREGNLRYSAKSLFSLVLGFISDNVDHIDSLIGFPEQIAEKLFSAAEARQKFTEPGAGLRALQKFTEAYGSLVLCSLCLRNRYLVISEKLEEIKSFRELTCLDLSCCKLGDEHELLEHLTNEALSSVTQLHLKDNCLSDAGVRKMTAPVRVMKRGLENLTLLDLSCNPEITDAGIGYLFSFRKLNCLDISGTGLKDIKTVKHKLQTHIGLVHSKVPLKEFDHSNCKTEGWADQIVLQWERVTAEAVKPRETSEPRAAAQRFYGKRSRAEAPLKCPLADTHMNSSEKLQFYKEKAPDCHGPVLKHEAISSQESKKSKKRPFEESETEQNNSSQPSKQKYVCLAVEDWDLLNSY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSYYLSSEN ------CCCCCCCCC | 23.61 | 24043423 | |
3 | Phosphorylation | -----MSYYLSSENH -----CCCCCCCCCC | 13.71 | 27642862 | |
4 | Phosphorylation | ----MSYYLSSENHL ----CCCCCCCCCCC | 7.87 | 27642862 | |
6 | Phosphorylation | --MSYYLSSENHLDP --CCCCCCCCCCCCC | 21.34 | 27642862 | |
7 | Phosphorylation | -MSYYLSSENHLDPG -CCCCCCCCCCCCCC | 39.56 | 27642862 | |
17 | Phosphorylation | HLDPGPIYMRENGQL CCCCCCEEECCCCEE | 8.02 | 27642862 | |
36 | Phosphorylation | LALDGVRSSLQKPRP EHHHHHHHHCCCCCC | 32.75 | 27251275 | |
37 | Phosphorylation | ALDGVRSSLQKPRPF HHHHHHHHCCCCCCC | 25.02 | 27251275 | |
40 | Ubiquitination | GVRSSLQKPRPFRLF HHHHHCCCCCCCCCC | 48.57 | 23000965 | |
40 | Acetylation | GVRSSLQKPRPFRLF HHHHHCCCCCCCCCC | 48.57 | 25953088 | |
52 | Phosphorylation | RLFPKGFSVELCMNR CCCCCCEEEEEECCC | 24.29 | 28348404 | |
66 | Ubiquitination | REDDTARKEKTDHFI CCCCCHHHHHCCEEE | 62.18 | - | |
68 | Ubiquitination | DDTARKEKTDHFIFT CCCHHHHHCCEEEEE | 63.39 | - | |
127 | Ubiquitination | SAAEARQKFTEPGAG HHHHHHHHCCCCCHH | 49.01 | 21906983 | |
129 | Phosphorylation | AEARQKFTEPGAGLR HHHHHHCCCCCHHHH | 48.59 | 25954137 | |
140 | Ubiquitination | AGLRALQKFTEAYGS HHHHHHHHHHHHHHH | 55.92 | - | |
145 | Phosphorylation | LQKFTEAYGSLVLCS HHHHHHHHHHHHHHH | 10.87 | 25954137 | |
147 | Phosphorylation | KFTEAYGSLVLCSLC HHHHHHHHHHHHHHH | 11.57 | 25954137 | |
165 | Ubiquitination | RYLVISEKLEEIKSF CEEEEEHHHHHHHCH | 55.17 | 21906983 | |
170 | Ubiquitination | SEKLEEIKSFRELTC EHHHHHHHCHHHCEE | 46.98 | 21906983 | |
209 | Ubiquitination | SVTQLHLKDNCLSDA HCCHHHCCCCCCCCC | 35.83 | 21963094 | |
220 | Sumoylation | LSDAGVRKMTAPVRV CCCCCCCCCCCCHHH | 37.89 | - | |
220 | Ubiquitination | LSDAGVRKMTAPVRV CCCCCCCCCCCCHHH | 37.89 | 29967540 | |
220 | Sumoylation | LSDAGVRKMTAPVRV CCCCCCCCCCCCHHH | 37.89 | - | |
256 | Phosphorylation | AGIGYLFSFRKLNCL CCHHHHEEEEECCCE | 22.88 | 24719451 | |
259 | Ubiquitination | GYLFSFRKLNCLDIS HHHEEEEECCCEECC | 41.88 | - | |
271 | Ubiquitination | DISGTGLKDIKTVKH ECCCCCCCHHHHHHH | 59.77 | 21963094 | |
274 | Ubiquitination | GTGLKDIKTVKHKLQ CCCCCHHHHHHHHHH | 58.35 | 22817900 | |
279 | Ubiquitination | DIKTVKHKLQTHIGL HHHHHHHHHHHCCCC | 36.25 | 29967540 | |
290 | Ubiquitination | HIGLVHSKVPLKEFD CCCCCCCCCCHHHCC | 32.75 | 21906983 | |
294 | Ubiquitination | VHSKVPLKEFDHSNC CCCCCCHHHCCCCCC | 50.71 | 21963094 | |
302 | Ubiquitination | EFDHSNCKTEGWADQ HCCCCCCCCCCCHHH | 54.59 | 29967540 | |
323 | Ubiquitination | RVTAEAVKPRETSEP EEEHHHCCCCCCCCH | 45.46 | 21906983 | |
349 | Acetylation | SRAEAPLKCPLADTH CCCCCCCCCCCCCCC | 32.52 | 25953088 | |
349 | Methylation | SRAEAPLKCPLADTH CCCCCCCCCCCCCCC | 32.52 | - | |
349 | Ubiquitination | SRAEAPLKCPLADTH CCCCCCCCCCCCCCC | 32.52 | 21963094 | |
355 | Phosphorylation | LKCPLADTHMNSSEK CCCCCCCCCCCHHHH | 19.88 | 22210691 | |
359 | Phosphorylation | LADTHMNSSEKLQFY CCCCCCCHHHHHHHH | 32.09 | 22210691 | |
360 | Phosphorylation | ADTHMNSSEKLQFYK CCCCCCHHHHHHHHH | 33.47 | 22210691 | |
362 | Ubiquitination | THMNSSEKLQFYKEK CCCCHHHHHHHHHHH | 49.92 | 29967540 | |
367 | Ubiquitination | SEKLQFYKEKAPDCH HHHHHHHHHHCCCCC | 54.77 | 29967540 | |
369 | Ubiquitination | KLQFYKEKAPDCHGP HHHHHHHHCCCCCCC | 62.15 | 29967540 | |
379 | Ubiquitination | DCHGPVLKHEAISSQ CCCCCHHCHHHCCCC | 39.37 | 29967540 | |
379 | Sumoylation | DCHGPVLKHEAISSQ CCCCCHHCHHHCCCC | 39.37 | - | |
379 | Acetylation | DCHGPVLKHEAISSQ CCCCCHHCHHHCCCC | 39.37 | 19827773 | |
379 | Sumoylation | DCHGPVLKHEAISSQ CCCCCHHCHHHCCCC | 39.37 | - | |
385 | Phosphorylation | LKHEAISSQESKKSK HCHHHCCCCCHHHHC | 31.67 | 28985074 | |
389 | Ubiquitination | AISSQESKKSKKRPF HCCCCCHHHHCCCCC | 61.38 | 22817900 | |
390 | Ubiquitination | ISSQESKKSKKRPFE CCCCCHHHHCCCCCC | 76.43 | 22817900 | |
392 | Ubiquitination | SQESKKSKKRPFEES CCCHHHHCCCCCCCC | 62.78 | 22817900 | |
393 | Ubiquitination | QESKKSKKRPFEESE CCHHHHCCCCCCCCC | 72.84 | 21906983 | |
399 | Phosphorylation | KKRPFEESETEQNNS CCCCCCCCCCCCCCC | 42.49 | 28555341 | |
401 | Phosphorylation | RPFEESETEQNNSSQ CCCCCCCCCCCCCCC | 52.75 | 28555341 | |
406 | Phosphorylation | SETEQNNSSQPSKQK CCCCCCCCCCCCCCC | 37.59 | - | |
407 | Phosphorylation | ETEQNNSSQPSKQKY CCCCCCCCCCCCCCE | 48.51 | 17525332 | |
411 | Ubiquitination | NNSSQPSKQKYVCLA CCCCCCCCCCEEEEE | 58.45 | 21906983 | |
413 | Ubiquitination | SSQPSKQKYVCLAVE CCCCCCCCEEEEEEC | 43.30 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRC42_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRC42_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRC42_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
SYNC_HUMAN | NARS | physical | 22939629 | |
ZC3HE_HUMAN | ZC3H14 | physical | 22939629 | |
SGT1_HUMAN | SUGT1 | physical | 26186194 | |
PXDC2_HUMAN | PLXDC2 | physical | 26186194 | |
AMRA1_HUMAN | AMBRA1 | physical | 26186194 | |
CUL3_HUMAN | CUL3 | physical | 28514442 | |
PXDC2_HUMAN | PLXDC2 | physical | 28514442 | |
SGT1_HUMAN | SUGT1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-407, AND MASSSPECTROMETRY. |